Back to News
Market Impact: 0.25

These stocks have strong total shareholder returns, says Morgan Stanley

MSMPCHPQFDXCVS
Capital Returns (Dividends / Buybacks)Corporate EarningsCompany FundamentalsAnalyst InsightsInvestor Sentiment & PositioningEnergy Markets & PricesTransportation & LogisticsTechnology & Innovation
These stocks have strong total shareholder returns, says Morgan Stanley

Morgan Stanley data show Russell 1000 cash balances rose to $2.1 trillion in Q3 while total shareholder return climbed to $1.9 trillion (up 1% Q/Q and 9.2% YoY), driven by $770 billion in dividends (+6.2% YoY) and $1.1 trillion of net buybacks (+11.3% YoY). The firm screened for Russell 1000 names with >6% TSR, dividend coverage >2x, positive net income and FCF CAGRs over two years and investment-grade ratings; notable inclusions include Marathon Petroleum (TSR ~18%, Q3 capital returned $926M incl. $650M buybacks), HP (TSR 15%, 4.93% yield, returned $1.9B in FY25), FedEx (TSR 7%, $500M buybacks, spin-off planned June 2026) and CVS (TSR 6.6%, strong Q3 and raised guidance; shares +78% YTD 2025).

Analysis

Market structure: Corporates sit on ~$2.1T cash while returning ~$1.9T to shareholders (=$770B dividends, $1.1T buybacks), which centrally benefits cash-rich, investment‑grade names (MPC, CVS, FDX) by boosting EPS and equity scarcity; losers are growth/small-cap firms that can’t match yield or buybacks, pressuring relative multiples. Pricing power shifts toward capital‑returning incumbents where buybacks reduce float and mechanically lift EPS per 1% reduction in shares; expect lower implied equity volatility and tighter IG credit spreads if buybacks continue. Risk assessment: Tail risks include regulatory clampdown on buybacks, a sharp crude price collapse (>-30% in 90 days) crushing refining margins (MPC), labor/operational disruption at FDX, or insurance loss shock at CVS; these are low probability but >10% P&L impact events. Timeline: immediate (days) earnings/guidance moves and buyback announcements; short term (3–9 months) spin‑off execution and winter refining margins; long term (12–36 months) HPQ AI execution and debt-funded buyback leverage effects. Hidden dependency: buybacks funded by cheap debt increase sensitivity to +100–200bp credit spread widening. Trade implications: Direct long candidates: CVS (operational beat + insurer recovery) and MPC (refining tailwinds), event‑driven long FDX into the June‑2026 Freight spin; size positions modestly (1–3% each) and use covered calls/put spreads to harvest yield. Options: sell 30–90 day 5–10% OTM puts on buyback names to collect premium, and finance 12‑18 month LEAPS on FDX (sell near-term calls to reduce cost). Enter within 2–6 weeks to capture seasonal refining strength and spin‑off rerating, trim on +20–30% moves. Contrarian angles: Consensus ignores that buyback activity may have peaked—an inverted yield curve or +25–50bp credit spread move could force pause and reverse EPS flows; conversely HPQ’s 25% YTD drop may underprice a multi‑quarter AI product cycle if execution stabilizes. Historical parallel: 2018 buyback peak then recession showed buyback-funded EPS growth is fragile; unintended consequence is higher leverage amplifying downside in a rates shock, increasing event‑driven dispersion and short‑squeeze risk.